Orthopediatrics Corp. (2X7)
XSTU 
Summary
2X7 Chart
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript
OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.39 per share a year ago.
Orthopediatrics Corp. (2X7) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Orthopediatrics Corp. ever had a stock split?
Orthopediatrics Corp. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | David R. Bailey CEO | XSTU Exchange | US68752L1008 ISIN |
| US Country | 562 Employees | - Last Dividend | - Last Split | 12 Oct 2017 IPO Date |
Overview
OrthoPediatrics Corp. stands as a pioneering medical device company primarily focused on the design, development, and marketing of anatomically appropriate implants, instruments, and specialty orthopedic braces for children facing orthopedic conditions. With its inception in 2006, the company has carved a niche within the pediatric orthopedic market both in the United States and on an international scale. OrthoPediatrics Corp.’s mission revolves around catering to pediatric orthopedic surgeons and caregivers, providing them with solutions specifically tailored for the unique anatomy of children. The company is headquartered in Warsaw, Indiana, where it continues to innovate and expand its reach to improve orthopedic care for children globally.
Products and Services
- PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti
OrthoPediatrics Corp. offers an extensive range of products tailored for pediatric trauma and deformity correction, scoliosis procedures for the treatment of spinal deformities, and sports medicine among others. Their product line includes implants such as the PediLoc and PediPlates which are designed for precision and compatibility with children’s anatomy. The company provides solutions for various orthopedic need—ranging from fracture stabilization (cannulated screws, PediFlex nail, PediNail) to complex deformity correction (RESPONSE Spine, The Fassier-Duval Telescopic Intramedullary System) and targeted growth modulation (GIROTM Growth Modulation System). Further, specialized products like the ACL Reconstruction System and the Mitchell Ponseti for clubfoot treatment showcase their dedication to addressing a wide spectrum of pediatric orthopedic challenges.
